{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Gastro-Intestinal+Cancer&page=24", "query": { "condition": "Gastro-Intestinal Cancer", "page": 24 }, "page_size": 10 }, "pagination": { "page": 24, "page_size": 10, "total_count": 4291, "total_pages": 430, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Gastro-Intestinal+Cancer&page=25&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Gastro-Intestinal+Cancer&page=23&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-13T02:46:00.552Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02358863", "title": "Molecularly Tailored Therapy for Patients With Metastatic Cancer of the Esophagus and Stomach", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Esophageal Cancer", "Gastric Cancer" ], "interventions": [ { "name": "Modified FOLFOX6", "type": "DRUG" }, { "name": "Docetaxel/Capecitabine", "type": "DRUG" }, { "name": "Cisplatin/Irinotecan", "type": "DRUG" }, { "name": "Cisplatin/Docetaxel", "type": "DRUG" }, { "name": "IRI/EPI", "type": "DRUG" }, { "name": "EPI/Docetaxel", "type": "DRUG" }, { "name": "Irinotecan/Docetaxel", "type": "DRUG" }, { "name": "Docetaxel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Georgetown University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 13, "start_date": "2015-02", "completion_date": "2016-11", "has_results": true, "last_update_posted_date": "2018-09-06", "last_synced_at": "2026-11-13T02:46:00.552Z", "location_count": 1, "location_summary": "Washington D.C., District of Columbia", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02358863" }, { "nct_id": "NCT02174549", "title": "Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Hepatocellular Carcinoma", "Gastrointestinal Cancer Metastatic", "Neuroendocrine Tumors" ], "interventions": [ { "name": "Tirapazamine", "type": "DRUG" }, { "name": "Conventional Transarterial Embolization (TAE)", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Teclison Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "20 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "20 Years to 99 Years" }, "enrollment_count": 25, "start_date": "2014-09", "completion_date": "2028-09-30", "has_results": false, "last_update_posted_date": "2026-04-20", "last_synced_at": "2026-11-13T02:46:00.552Z", "location_count": 2, "location_summary": "Palo Alto, California • Philadelphia, Pennsylvania", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02174549" }, { "nct_id": "NCT02163187", "title": "Sacral Neuromodulation (SNM) With InterStimTM for Bowel Dysfunction Following Surgery for Rectal Cancers With Sphincter Preservation", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Rectal Cancer", "for Bowel Dysfunction Following Surgery for Rectal Cancers" ], "interventions": [ { "name": "Implantation of the InterStimTM", "type": "DEVICE" }, { "name": "MSK BFI questionnaires", "type": "BEHAVIORAL" }, { "name": "The Low Anterior Resection Score (LARS) questionnaires", "type": "BEHAVIORAL" }, { "name": "The EuroQOL5D questionnaires", "type": "BEHAVIORAL" }, { "name": "The Fecal incontinence Quality of Life Scale (FIQOL) questionnaires", "type": "BEHAVIORAL" } ], "intervention_types": [ "DEVICE", "BEHAVIORAL" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 4, "start_date": "2014-06-10", "completion_date": "2016-12-19", "has_results": true, "last_update_posted_date": "2018-02-05", "last_synced_at": "2026-11-13T02:46:00.552Z", "location_count": 2, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02163187" }, { "nct_id": "NCT02788214", "title": "Helicobacter Pylori Genome Project (HpGP)", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Gastric Cancer", "Non-Atrophic Gastritis", "Intestinal Metaplasia" ], "interventions": [], "intervention_types": [], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "30 Years to 70 Years" }, "enrollment_count": 1000, "start_date": "2016-07-27", "completion_date": "2020-05-15", "has_results": false, "last_update_posted_date": "2020-12-19", "last_synced_at": "2026-11-13T02:46:00.552Z", "location_count": 7, "location_summary": "Batesville, Arkansas • Stanford, California • Athens, Georgia + 4 more", "locations": [ { "city": "Batesville", "state": "Arkansas" }, { "city": "Stanford", "state": "California" }, { "city": "Athens", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02788214" }, { "nct_id": "NCT03384316", "title": "Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Neoplasms", "Prostate Cancer", "Lung Cancer", "Breast Cancer", "Colon Cancer" ], "interventions": [ { "name": "ETBX-051; adenoviral brachyury vaccine", "type": "BIOLOGICAL" }, { "name": "ETBX-061; adenoviral Mucin-1 (MUC1) vaccine", "type": "BIOLOGICAL" }, { "name": "ETBX-011; adenoviral Carcinoembryonic antigen (CEA) vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 11, "start_date": "2018-01-31", "completion_date": "2020-08-24", "has_results": true, "last_update_posted_date": "2020-09-09", "last_synced_at": "2026-11-13T02:46:00.552Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03384316" }, { "nct_id": "NCT03209349", "title": "Investigation of Cecal Intubation Rates and Pain Levels Between Water Exchange and Air Insufflation Flexible Sigmoidoscopy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Colorectal Cancer" ], "interventions": [ { "name": "Water Exchange Sigmoidoscopy", "type": "PROCEDURE" }, { "name": "Air Insufflation Sigmoidoscopy", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Kelowna Gastroenterology Associates", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": "74 Years", "sex": "ALL", "summary": "50 Years to 74 Years" }, "enrollment_count": 90, "start_date": "2017-06-14", "completion_date": "2022-11-03", "has_results": false, "last_update_posted_date": "2022-11-07", "last_synced_at": "2026-11-13T02:46:00.552Z", "location_count": 1, "location_summary": "North Hills, California", "locations": [ { "city": "North Hills", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03209349" }, { "nct_id": "NCT07224750", "title": "A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hepatocellular Carcinoma (HCC)", "Cholangiocarcinoma", "Pancreatic Ductal Adenocarcinoma (PDAC)", "Esophageal Squamous Cell Carcinoma (ESCC)", "Gastric Cancer (GC)", "Colorectal Cancer Screening" ], "interventions": [], "intervention_types": [], "sponsor": "City of Hope Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1000, "start_date": "2024-06-21", "completion_date": "2028-06-18", "has_results": false, "last_update_posted_date": "2026-07-07", "last_synced_at": "2026-11-13T02:46:00.552Z", "location_count": 1, "location_summary": "Duarte, California", "locations": [ { "city": "Duarte", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07224750" }, { "nct_id": "NCT00394615", "title": "Metabolic Imaging Predict Histopathologic Response to Preop ChemoXRT for Locally Advanced Rectal CA", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Rectal Cancer" ], "interventions": [ { "name": "Metabolic Imaging", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 15, "start_date": "2003-10", "completion_date": "2005-10", "has_results": false, "last_update_posted_date": "2010-03-29", "last_synced_at": "2026-11-13T02:46:00.552Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00394615" }, { "nct_id": "NCT04701476", "title": "TATE and Pembrolizumab (MK3475) in mCRC and NSCLC", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Colorectal Cancer; Lung Cancer" ], "interventions": [ { "name": "TATE and pembrolizumab", "type": "DRUG" }, { "name": "TAS-102 pill", "type": "DRUG" }, { "name": "Regorafenib Pill", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teclison Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 110, "start_date": "2021-05-20", "completion_date": "2027-09-30", "has_results": false, "last_update_posted_date": "2026-04-16", "last_synced_at": "2026-11-13T02:46:00.552Z", "location_count": 1, "location_summary": "Orange, California", "locations": [ { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04701476" }, { "nct_id": "NCT05010850", "title": "SafeHeal Colovac Colorectal Anastomosis Protection Device Evaluation (SAFE-2) Pivotal Study", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Colorectal Cancer", "Rectal Cancer", "Rectal Tumor", "Rectal/Anal" ], "interventions": [ { "name": "Colovac", "type": "DEVICE" }, { "name": "Stoma Creation", "type": "PROCEDURE" } ], "intervention_types": [ "DEVICE", "PROCEDURE" ], "sponsor": "SafeHeal Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 18, "start_date": "2022-01-17", "completion_date": "2024-01-19", "has_results": true, "last_update_posted_date": "2025-07-03", "last_synced_at": "2026-11-13T02:46:00.552Z", "location_count": 10, "location_summary": "Los Angeles, California • Tampa, Florida • Worcester, Massachusetts + 4 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Tampa", "state": "Florida" }, { "city": "Worcester", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05010850" } ] }